Inspection Record

Germiphene Corporation — Health Canada Inspection Findings

Health CanadaInspected 2025-03-17 15 findingsOther quality systemComplaint and recall handlingDeviation, CAPA, and investigationEquipment and facilityStability and storageComputer system validationMaterial and supplier controlLaboratory and QC controlsContamination controlCleaning validation

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

The implementation of a self-inspection program was inadequate.

2Complaint and recall handling

The written procedures for recalls were inadequate.

3Deviation, CAPA, and investigation

The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate.

4Other quality system

The implementation and/or the effectiveness of the sanitation program in preventing unsanitary conditions was inadequate.

5Equipment and facility

Materials, bulk containers, major items of equipment, and/or the rooms were not properly identified. The protection of products and/or materials from contamination was inadequate.

6Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate.

7Stability and storage

The design of the drug stability study was inadequate and/or not justified with a documented rationale.

8Computer system validation

The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate.

9Material and supplier control

A reduced retesting program for raw materials was in place without the raw material vendor certification.

10Laboratory and QC controls

The quality control department's approval was inadequate for raw materials, packaging materials, labelling, finished products, and/or products being reprocessed.

11Equipment and facility

Evaluation of production processes, equipment, and/or materials was inadequate. The recorded information or details were inadequate.

12Contamination control

The sanitation programs were not adequately designed to identify and/or reduce the risks of contamination.

13Equipment and facility

The training of personnel in good manufacturing practices and/or the maintenance of records was inadequate. The job descriptions for personnel, the authority given to personnel, and/or the delegation of duties was inadequate and/or undocumented.

14Laboratory and QC controls

The creation, maintenance, processing, and/or review of laboratory data was inadequate.

15Cleaning validation

The sanitation program was inadequate in its cleaning procedures, frequency of cleaning, procedures for waste disposal, and/or pest control measures.

About this record

Extracted automatically from the document of the Health Canada inspection on 2025-03-17. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Germiphene Corporation company profile — full history Health Canada documents, 2025 Go to Findings search